Earnings ·
Outset Medical, Inc. reported second quarter 2026 financial results with net revenue of $31.6 million, a 1% increase…
OMOutset Medical, Inc.
Outset Medical, Inc. reported second quarter 2026 financial results with net revenue of $31.6 million, a 1% increase year-over-year and a 14% sequential rise. Gross margin expanded to 42%, up more than 400 basis points from the prior-year period, while operating expenses remained stable at $29.0 million. The company reported a net loss of $18.0 million compared to $18.5 million in the same period last year and ended the quarter with $151 million in cash and equivalents. Outset Medical signed a three-year, $40 million agreement with HCA Healthcare to refresh its Tablo dialysis systems across the nation's largest health system. The company reiterated its 2026 revenue guidance of $125 million to $130 million. Outset Medical is a medical technology company that manufactures and services the Tablo Hemodialysis System for clinical use in hospitals and homes.